With Novo Nordisk’s name already synonymous with treatments for diabetes and obesity, the Danish drugmaker has been making a ...

The global beauty sector is on track to make $548 billion by the end of the year, up 4.5 per cent from 2023 with a forecasted ...

EU regulator supports a label expansion of Novo Nordisk’s diabetes drug to reflect its potential to lower the risk of ...

Weight-loss medications like Ozempic and Wegovy are "a modern medical miracle" that is being used irresponsibly, according to an obesity specialist. "This medicine is a modern medical miracle ...